In silico evaluation of erythrinic alkaloids from Erythrina verna in human crystallographic model GABAA R-β3 (4COF) and GABAA R-α1-β2-γ2 (6X3X)
DOI:
https://doi.org/10.5902/2179460X91221Keywords:
Mulungu, Erythrina, In silico, Anxiolytic effect, Multivariate analysisAbstract
Erythrina verna, known as mulungu, is a medicinal plant recognized for anxiolytic effects attributed to erythrinic alkaloids. This research aims to enhance our understanding of the mechanism of these alkaloids through in silico studies and explore their potential interaction with GABAA sub-receptors. Molecular modeling and docking simulations were performed to evaluate the conformational structure and interaction energies of the molecules as well as toxicity prediction. Multivariate statistical analyses were utilized to highlight the influence of binding affinity. The results indicate strong interactions of the erythrinic alkaloids with key amino acid residues from the GABAA receptor, while multivariate analysis revealed significant interaction patterns for erythradine and erysortrine. Mutagenic, tumorigenic, irritant, or reproductive risks were not observed in these molecules. So, erythrinic alkaloids exposure demonstrates safety and efficacy as a natural anxiolytic. It also contributes to our understanding of erythrinic alkaloids’ pharmacological effects and supports the further development of natural anxiolytics for therapeutic applications.
Downloads
References
Carvalho, A. C. C. S., Almeida, D.S., Melo, M. G. D., Cavalcanti, S. C. H. & Marçal, R. M. (2009). Evidence of the mechanism of action of Erythrina velutina Willd (Fabaceae) leaves aqueous extract. J. Ethnopharmacol., 122(2), 374–378. DOI: https://doi.org/10.1016/j.jep.2008.12.019 DOI: https://doi.org/10.1016/j.jep.2008.12.019
Cemin, P., Ribeiro, S. R., Oliveira, F. C., Wagner, R. & Sant’Anna, V. (2024). Study of volatile compounds and sensory profile of Brazilians’ cocoa liquors. Int. J. Gastron. Food Sci., 37, 1-10. DOI: https://doi.org/10.1016/j.ijgfs.2024.100967 DOI: https://doi.org/10.1016/j.ijgfs.2024.100967
Chu, H. B., Tan, Y. De, Li, Y. J., Cheng, B. B., Rao, B. Q. & Zhou, L. S. (2019). Anxiolytic and anti-depressant effects of hydroalcoholic extract from Erythrina variegata and its possible mechanism of action. Afr. Health Sci., 19(3), 2526–2536. DOI: https://doi.org/10.4314/ahs.v19i3.28 DOI: https://doi.org/10.4314/ahs.v19i3.28
Clent, B. A., Wang, Y., Britton, H. C., Otto, F., Swain, C. J., Todd, M. H., Wilden, J. D. & Tabor, A. B. (2021). Molecular Docking with Open Access Software: Development of an Online Laboratory Handbook and Remote Workflow for Chemistry and Pharmacy Master’s Students to Undertake Computer-Aided Drug Design. J. Chem. Educ., 98(9), 2899–2905. DOI: https://doi.org/10.1021/ACS.JCHEMED.1C00289 DOI: https://doi.org/10.1021/acs.jchemed.1c00289
Craveiro, A. C. S., Carvalho, D. M. M., Nunes, R. D. S., Fakhouri, R., Rodrigues, S. A. & Teixeira-Silva, F. (2008) Toxicidade aguda do extrato aquoso de folhas de Erythrina velutina em animais experimentais. Revista Brasileira de Farmacognosia, 18:739–743. DOI: https://doi.org/10.1590/S0102-695X2008000500018 DOI: https://doi.org/10.1590/S0102-695X2008000500018
Flausino Junior, O. A. (2006) Análise fitoquímica e estudo biomonitorado de Erythrina mulungu (Leguminosae - Papilionaceae) em camundongos submetidos a diferentes modelos animais de ansiedade. [Tese de Doutorado em Ciências, Universidade de São Paulo]. Biblioteca Digital de Teses e Dissertações da USP. http://www.teses.usp.br/teses/disponiveis/59/59134/tde-22062007-134229/
Flausino Junior, O. A., Santos, L. D. A., Verli, H., Pereira, A. M., Bolzani, V. D. S. & Nunes-de-Souza, R. L. (2007). Anxiolytic effects of erythrinian alkaloids from Erythrina mulungu. J. Nat. Prod., 70(1), 48–53. DOI: https://doi.org/10.1021/np060254j DOI: https://doi.org/10.1021/np060254j
Iturriaga-Vásquez, P., Carbone, A., García-Beltrán, O., Livingstone, P. D., Biggin, P. C., Cassels, B. K., Wonnacott, S., Zapata-Torres, G. & Bermudez, I. (2010). Molecular determinants for competitive inhibition of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol., 78(3), 366–375. DOI: https://doi.org/10.1124/mol.110.065490 DOI: https://doi.org/10.1124/mol.110.065490
Kim, J. J., Gharpure, A., Teng, J., Zhuang, Y., Howard, R. J., Zhu, S., Noviello, C. M., Walsh, R. M., Lindahl, E. & Hibbs, R. E. (2020). Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature, 585(7824), 303–308. DOI: https://doi.org/10.1038/s41586-020-2654-5 DOI: https://doi.org/10.1038/s41586-020-2654-5
Miller, P. S. & Aricescu, A. R. (2014). Crystal structure of a human GABAA receptor. Nature, 512(7514), 270. DOI: https://doi.org/10.1038/NATURE13293 DOI: https://doi.org/10.1038/nature13293
Olsen, R.W. (2018). GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology, 136, 10–22. DOI: https://doi.org/10.1016/j.neuropharm.2018.01.036 DOI: https://doi.org/10.1016/j.neuropharm.2018.01.036
Onusic, G. M., Nogueira, R. L., Pereira, A. M. S., Flausino Junior, O. A. & Viana, M. B. (2003). Effects of Chronic Treatment with a Water-Alcohol Extract from Erythrina mulungu on Anxiety-Related Responses in Rats. Biol. Pharm. Bull., 26(11), 1538-1542. DOI: https://doi.org/10.1248/bpb.26.1538 DOI: https://doi.org/10.1248/bpb.26.1538
Onusic G. M., Nogueira R. L., Pereira, A. M. S. & Viana, M. B. (2002). Effect of acute treatment with a water-alcohol extract of Erythrina mulungu on anxiety-related responses in rats. Brazilian Journal of Medical and Biological Research, 35(4), 473–477. DOI: https://doi.org/10.1590/S0100-879X2002000400011 DOI: https://doi.org/10.1590/S0100-879X2002000400011
Pitchaiah, G., Viswanatha, G. L., Srinath, R., & Nandakumar, K. (2008). Pharmacological evaluation of alcoholic of stem bark of erythrina variegata for anxiolytic and anticonvulsant activity in mice. Pharmacologyonline, 3, 934-947.
Ribeiro, M. D., Onusic, G.M., Poltronieri, S. C. & Viana, M. B. (2006) Effect of Erythrina velutina and Erythrina mulungu in rats submitted to animal models of anxiety and depression. Brazilian Journal of Medical and Biological Research, 39(2), 263–270. DOI: https://doi.org/10.1590/S0100-879X2006000200013 DOI: https://doi.org/10.1590/S0100-879X2006000200013
Rogers, K. L., Grice, I. D. & Griffiths, L. R. (2001). Modulation of in vitro platelet 5-HT release by species of Erythrina and Cymbopogon. Life Sci., 69(15),1817–1829. DOI: https://doi.org/10.1016/S0024-3205(01)01266-8 DOI: https://doi.org/10.1016/S0024-3205(01)01266-8
Sahila, M. M., Pulikkal, B. P., Bandaru, S., Nayarisseri, A. & Doss, V. A. (2015). Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives. Bioinformation, 11(6), 280. DOI: https://doi.org/10.6026/97320630011280 DOI: https://doi.org/10.6026/97320630011280
Schleier, R., Quirino, C. S. & Rahme, S. (2016) Erythrina mulungu – descrição botânica e indicações clínicas a partir da antroposofia. Arte Médica Ampliada, 36(4), 162–167.
Sieghart, W. & Savic, M. M. (2018). International union of basic and clinical pharmacology. CVI: GABAA receptor subtype-and function-selective ligands: Key issues in translation to humans. Pharmacol. Rev., 70(4), 836–878. DOI: https://doi.org/10.1124/PR.117.014449 DOI: https://doi.org/10.1124/pr.117.014449
Sigel, E. & Ernst, M. (2018). The Benzodiazepine Binding Sites of GABAA Receptors. Trends Pharmacol. Sci., 39(7), 659–671. DOI: https://doi.org/10.1016/j.tips.2018.03.006 DOI: https://doi.org/10.1016/j.tips.2018.03.006
Tretter, V., Ehya, N., Fuchs, K. & Sieghart, W. (1997) Stoichiometry and Assembly of a Recombinant GABA A Receptor Subtype. J. Neurosci., 17(8), 2728-2737. DOI: https://doi.org/10.1523/JNEUROSCI.17-08-02728 DOI: https://doi.org/10.1523/JNEUROSCI.17-08-02728.1997
Vasconcelos, S. M. M., Lima, N. M., Sales, G. T. M., Cunha, G. M. A., Aguiar, L. M. V., Silveira, E. R., Rodrigues, A. C. P., Macedo, D. S., Fonteles, M. M. F., Sousa, F. C. F. & Viana, G. S. B. (2007). Anticonvulsant activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu. J. Ethnopharmacol., 110(2), 271–274. DOI: https://doi.org/10.1016/J.JEP.2006.09.023 DOI: https://doi.org/10.1016/j.jep.2006.09.023
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ciência e Natura
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
To access the DECLARATION AND TRANSFER OF COPYRIGHT AUTHOR’S DECLARATION AND COPYRIGHT LICENSE click here.
Ethical Guidelines for Journal Publication
The Ciência e Natura journal is committed to ensuring ethics in publication and quality of articles.
Conformance to standards of ethical behavior is therefore expected of all parties involved: Authors, Editors, Reviewers, and the Publisher.
In particular,
Authors: Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review Articles should also be objective, comprehensive, and accurate accounts of the state of the art. The Authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding Author should ensure that there is a full consensus of all Co-authors in approving the final version of the paper and its submission for publication.
Editors: Editors should evaluate manuscripts exclusively on the basis of their academic merit. An Editor must not use unpublished information in the editor's own research without the express written consent of the Author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.
Reviewers: Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that Authors can use them for improving the paper. Any selected Reviewer who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the Editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
